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Habitual Caffeine Consumption Does Not Affect the Ergogenicity 
of Coffee Ingestion During a 5 km Cycling Time Trial 
Neil D. Clarke and Darren L. Richardson 
Coventry University 
There is growing evidence that caffeine and coffee ingestion prior to exercise provide similar ergogenic benefits. However, there 
has been a long-standing paradigm that habitual caffeine intake may influence the ergogenicity of caffeine supplementation. The 
aim of the present study was to investigate the effect of habitual caffeine intake on 5-km cycling time-trial performance following 
the ingestion of caffeinated coffee. Following institutional ethical approval, in a double-blind, randomized, crossover, placebo-
controlled design, 46 recreationally active participants (27 men and 19 women) completed a 5-km cycling time trial on a cycle 
ergometer 60 m in following the ingestion of 0.09 g/kg coffee providing 3 mg/kg of caffeine, or a placebo. Habitual caffeine 
consumption was assessed using a caffeine consumption questionnaire with low habitual caffeine consumption defined as <3 and 
≥6 mg · kg−1 · day−1 defined as high. An analysis of covariance using habitual caffeine intake as a covariant was performed to 
establish if habitual caffeine consumption had an impact on the ergogenic effect of coffee ingestion. Sixteen participants were 
classified as high-caffeine users and 30 as low. Ingesting caffeinated coffee improved 5-km cycling time-trial performance by 
8 ± 12 s; 95% confidence interval (CI) [5, 13]; p < .001; d = 0.30, with low, 9±14 s; 95% CI [3, 14]; p = .002; d = 0.18, and high, 
8 ± 10 s; 95% CI [−1, 17]; p = .008; d = 0.06, users improving by a similar magnitude, 95% CI [−12, 12]; p = .946; d = 0.08. In 
conclusion, habitual caffeine consumption did not affect the ergogenicity of coffee ingestion prior to a 5-km cycling time trial. 
Keywords: exercise performance, ergogenic, individual responses, supplements 
Caffeine (1,3,7-trimethylxanthine) is consumed daily by 
approximately 80% of the world’s population (Ogawa & Ueki, 
2007). Furthermore, due to the ergogenic potential, urine caffeine 
data suggests that caffeine is widely ingested prior to competition 
(Aguilar-Navarro et al., 2019), and athletes regularly consume 
caffeine in the form of coffee (Desbrow & Leveritt, 2006). 
However, the majority of the research to date typically focuses 
on the ingestion of caffeine, rather than coffee (Higgins, Straight, & 
Lewis, 2016). Finally, the responses to caffeine are often variable 
(Spriet, 2014) and possibly affected by a number of factors such as 
training status, genotype, and habitual caffeine use (Pickering & 
Grgic, 2019a). 
Caffeine’s primary ergogenic mechanisms are considered to 
arise from the antagonism of adenosine receptors leading to an 
increase in neurotransmitter release, motor unit firing rates, pain 
suppression, reduced fatigue, and improved neuromuscular perfor-
mance (Davis & Green, 2009; Graham, 2001). However, there has 
been a long-standing paradigm that habitual caffeine intake may 
influence the ergogenicity of caffeine supplementation (Sökmen 
et al., 2008), and thus coffee ingestion. Habitual caffeine ingestion 
is associated with an upregulation in the number of adenosine 
receptors (Fredholm, 1982), potentially reducing the efficacy of the 
blocking action of caffeine. Furthermore, Svenningsson et al. 
(1999) reported caffeine-tolerant rats had downregulated levels 
of adenosine A2A receptors and the corresponding mRNA in rostral 
parts of striatum, potentially affecting caffeine metabolism, and 
thus altering the ergogenic effect of coffee. Therefore, caffeine 
The authors are with the Faculty of Health and Life Sciences, School of Life 
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coventry.ac.uk) is corresponding author. 
habituation is commonly identified as a factor influencing the 
ergogenic effect of caffeine (Sökmen et al., 2008), although 
research provides conflicting findings (Pickering & Kiely, 2019), 
and with few studies reporting blood or salivary caffeine concen-
trations, or assessing men and women. 
To date, few studies report no effect of habitual caffeine intake 
on exercise performance following caffeine ingestion (≤25 vs. 
>300 mg/day [Dodd, Brooks, Powers, & Tulley, 1991]; 58– 
351 mg/day [Gonçalves et al., 2017]; 27 ± 36 vs. 358 ± 210 mg/ 
day [Sabol, Grgic, & Mikulic, 2019]; 14 ± 17 vs. 777 ± 295 mg/day 
[Tarnopolsky & Cupido, 2000]). Similarly, Irwin et al. (2011) 
concluded that acute caffeine supplementation provides an ergogenic 
benefit in regular caffeine users regardless of any withdrawal period. 
In contrast, Bell and McLellan (2002) reported that nonusers 
(<50 mg/day) exhibited a greater, and longer lasting, ergogenic 
effect following the ingestion of 5 mg/kg of caffeine than regular 
caffeine users (≥300 mg/day). Furthermore, Lara et al. (2019) 
reported that the ergogenic effects of caffeine (3 mg · kg−1 · day−1) 
after 20 days of consecutive ingestion to be lower than the first day 
of ingestion. In addition, Beaumont et al. (2017) demonstrated that 
the ergogenic effect of caffeine to be reduced after 28 days of caffeine 
ingestion (Days 1–7: 1.5 mg/kg; Days 8–28: 3 mg/kg), suggesting 
the development of caffeine tolerance. These findings provide 
equivocal evidence for the existence of a reduction in caffeine’s 
ergogenicity with continuous ingestion. However, the variation in 
these findings could be due to different thresholds to categorize 
individuals and the different performance protocols. Consequently, 
the relationship between habitual caffeine use and performance is 
poorly understood (Filip, Wilk, Krzysztofik, & Del Cosco, 2020), 
and no previous study has investigated the effect of caffeine habitu-
ation on the ergogenic effect of coffee ingestion. Therefore, the aim 
of the present study was to investigate the effect of habitual caffeine 
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intake on 5-km cycling time-trial performance following the inges-
tion of caffeinated coffee. 
Methods 
In a double-blind, Latin-square randomized, crossover, placebo-
controlled design, in which participants and treatments were the 
blocking factors, 46 recreationally active participants (27 men: 
[mean ± SD] age = 29 ± 6 years, height = 180 ± 6 cm, body 
˙mass = 78 ± 12 kg; VO2max = 55  11 ml · kg−1 · min−1 and 19 
women: age = 28 ± 6 years, height = 166 ± 7 cm, body mass = 
72 ± 11 kg; V̇O2max = 41  9 ml · kg−1 · min−1) completed a 5-km 
cycling time trial on a cycle ergometer 60 min following the ingestion 
of 0.09 g/kg coffee providing 3 mg/kg of caffeine, or a placebo 
(PLA). A caffeine dose of 3 mg/kg was ingested as this dose has been 
demonstrated to offer ergogenic effects (Pickering & Grgic, 2019b). 
Participants were recreational cyclists and had consistently trained 
on average 2 ± 1 times per week for at least 1 year. Originally, 54 
participants were recruited, but seven were excluded due to not 
fulfilling the caffeine consumption inclusion criteria. All trials were 
conducted at the same time of day (09:00–12:00) and were consistent 
for each participant in order to minimize circadian variation (Drust, 
Waterhouse, Atkinson, Edwards, & Reilly, 2005). Women were 
regularly taking a monophasic oral contraceptive pill for at least 
3 months prior to the first trial. To control for possible differences 
during the oral contraceptive cycle, testing was performed during 
Days 5–8 and  19–22 of the cycle, as no changes in energy metabo-
lism have been reported between these time points (Lynch, De Vito, 
& Nimmo,  2001). All procedures were undertaken in accordance 
with the Declaration of Helsinki and approved by Coventry Univer-
sity institutional ethics committee. Participants were made fully 
aware of the exact procedures, including any risks and benefits of 
participation in the study before providing written informed consent. 
Habitual caffeine consumption was assessed using a caffeine 
consumption questionnaire and assessed caffeine content (Bühler 
et al., 2014), and based on the proposals by Filip et al. (2020), low 
users included naïve to mild habitual caffeine consumption 
defined as <3 mg · kg−1 · day−1 and ≥6 mg · kg−1 · day−1 defined 
as high users. The doses were chosen in order to make sure that 
there was a clear distension between the two groups. In addition, 
each participant completed a 24-hr dietary record prior to the first 
trial; this was then photocopied and handed back to the 
participants so that the same diet could be repeated for subsequent 
trials. Participants were also instructed to abstain from caffeine, 
alcohol, and strenuous activity for at least 12 hr, which along with 
diet, was confirmed verbally prior to each trial. Nescafe original 
coffee (from the same batch; Nescafé Original, Nestlé, United 
Kingdom) was used and dissolved in 300 ml of water (58 ± 3 °C) 
and served in lidded cups. Participants were given a maximum of 
10 min to consume the beverage, and the 60-min rest period 
started once the cup was emptied (Figure 1). The PLA trial was 
water of the same volume and temperature with coffee flavor 
(Espresso Coffee Flavoring Compound; MSK Ingredients, Ches-
terfield, United Kingdom) and color (Brown Food Coloring, 
Lakeland, United Kingdom). The coffee and PLA samples 
were analyzed externally for their caffeine content (Laserchrom 
HPLC Laboratories Ltd, Rochester, United Kingdom) using a 
high-performance liquid chromatography method. The coffee 
sample provided 35.1 mg of caffeine per 1 g of coffee, and the 
PLA contained no traces of caffeine. Based on this analysis, it was 
calculated that each participant consumed 0.09 g/kg of coffee to 
achieve the 3 mg/kg of caffeine required. 
Before the experimental trials, participants completed a graded 
exercise test to exhaustion on a cycle ergometer (Wattbike Pro; 
Wattbike Ltd, Nottingham, United Kingdom) and a familiarization 
of the 5-km time trial, performed on the same day. Prior to all trials, 
participants performed a 2-min pretest warm-up. The protocol 
consisted of 2 min of cycling at a self-selected power output, 
2 min of cycling including three 6-s maximal sprints, and finished 
with 3 min of cycling at a self-selected power output (Bellinger & 
Minahan, 2014). Following completion of the warm-up, there was 
a 60-s period where the participants sat passively before a stan-
dardized countdown to initiate the time trial. The participants then 
performed a 5-km cycling time trial where they were instructed to 
complete the distance as fast as possible. During each time trial, 
participants had access to the distance remaining, and with the 
exception of verbal encouragement, no other information was 
provided. The gearing was self-selected by the participants on 
the Wattbike during the familiarization trial and then replicated 
during each time trial. Trials were separated by a minimum period 
of 48 hr to ensure recovery and caffeine washout. In order to 
establish any learning effect, following completion of the experi-
mental trials, 5-km time to completion was compared between 
the familiarization trial and PLA trial of the main experimental 
using a paired samples t test. No significant difference between 
Figure 1 — Schematic of the experimental protocol. 
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trials was observed, familiarization: 487 ± 50 s, PLA: 490 ± 49 s; 
t(45) = 0.265; p = .792; 95% confidence interval (CI) [−19, 25]; 
Hedge’s g = −0.06, 95% CI [−0.47, 0.35]. 
Saliva samples (minimum 0.5 ml by the passive drool tech-
nique) were obtained immediately before fluid ingestion, 1-hr 
postingestion prior to commencing the time trial, and 120 s 
following the time trial. Participants expectorated into a 20-ml 
plastic cup, and the sample was then transferred to a capped glass 
vial that was immediately placed in a −80 °C freezer for subsequent 
analysis of caffeine concentration using a standard enzyme-linked 
immunosorbent assay kit (Caffeine ELISA Kit; Creative Diagnos-
tics, Shirley, NY). Saliva samples have been shown to be valid 
surrogates of plasma measures of caffeine in multiple studies 
(Scott, Chakraborty, & Marks, 1984; Suzuki, Uematsu, Mizuno, 
Fujii, & Nakashima, 1989). For example, data from Scott et al. 
(1984) revealed a strong correlation (r = .94) between determina-
tions of serum and saliva caffeine concentrations. Heart rate was 
measured throughout each time trial (Polar RS400; Polar Electro 
Oy, Kempele, Finland), and at the same time points, a capillary 
blood sample was drawn from the index finger for determination 
of blood lactate concentration (Biosen C-line; EKF-diagnostic 
GmbH, Barleben, Germany). 
A statistical power analysis was performed for sample size 
estimation based on the race time from a previous coffee-ingestion 
study (Clarke, Richardson, Thie, & Taylor, 2018). As this study did 
not present correlation values between conditions, a conservative 
effect size value of 0.5 was used for the calculation. Consequently, 
an a priori power calculation suggested a sample size of 11 
participants was deemed necessary to detect a difference between 
conditions given an estimated effect size of 0.44, a 1 − β error 
probability of .95 and an alpha value of <.05. A mixed-design 2 
(between-subject factor; high-/low-caffeine users) × 2 (within-
subject factor; condition: caffeinated coffee, PLA) an analysis of 
variance was applied. Where any differences were identified, post 
hoc pairwise comparisons with Bonferroni correction were con-
ducted. In addition, an analysis of covariance was performed using 
habitual caffeine intake and baseline performance as covariates in 
order to further establish the ergogenic effect of coffee ingestion 
and the effect of habitual caffeine intake and initial performance. 
Linear regressions were performed between habitual caffeine 
intake, postdrink salivary caffeine concentration, and the absolute 
change in performance. All data were analyzed using IBM SPSS 
Statistics for Windows (version 25.0; IBM Corp., Armonk, NY). 
Finally, 95% CIs and effect sizes, (partial eta squared [η2]) definedp
as trivial (<.10), small (.10–.24), moderate (.25–.39), or large 
(≥.40), and Hedge’s g defined as trivial (≤0.19), small (0.20–0.49), 
moderate (0.50–0.79), and large (≥0.80) according to the cutoffs 
suggested by Cohen (1992), were also calculated. 
Results 
A total of 16 participants (11 men and five women) were classified 
as high-caffeine users, 6 ± 2 mg · kg−1 · day−1; 95% CI [5, 7]; 
415 ± 133 mg/day; 95% CI [344, 486], and 30 as low, 16 men 
and 14 women; 2 ± 1 mg · kg−1 · day−1; 95% CI [1, 2]; 153 ± 99 mg/ 
day; 95% CI [116, 190]. Coffee ingestion increased salivary 
caffeine levels, F(3, 132) = 278.553; p < .001; 95% CI [6.1, 7.9]; 
η2p = .86 (Figure 2a), but with no difference between low, 
7.3 ± 2.3 μg/ml; 95% CI [6.5, 8.0]; Hedge’s g = 4.13, 95% CI 
[3.25, 5.01], and high, 6.7 ± 1.5 μg/ml; 95% CI [5.7, 7.8]; Hedge’s 
g = 4.88, 95% CI [3.35, 6.14], users, F(1, 44) = 1.017; p = .319; 
95% CI [−0.4, 1.2]; η2 = .02 (Figure 2b).p 
Overall, performance in the coffee trial (482 ± 46 s) was faster 
than the PLA, 490 ± 49 s; t(45) = −4.523; p < .001; 95% CI [−12, 
−5]; Hedge’s g = 0.17, 95% CI [−0.24, 0.56], trial. Low-caffeine 
users (Coffee: 477 ± 49 s; PLA 486 ± 52 s) and high users per-
formed similarly, Coffee: 490 ± 40 s; PLA 497 ± 0. s; F(1, 
44) = 0.679; p = .415; 95% CI [−41, −17]; η2 = .02). Ingesting p 
coffee improved 5-km cycling time-trial performance by 
8 ± 12 s, 95% CI [5, 13]; F(1, 44) = 18.032; p < .001; η2 = .30 p 
(Figure 3a), with low, 9 ± 14 s; 95% CI [3, 14]; p = .002; Hedge’s 
g = 0.18, 95% CI [−0.33, 0.68], and high users, 8 ± 10 s; 95% CI 
[−1, 17]; p = .008; Hedge’s g = 0.17, 95% CI [−0.53, 0.86], 
improving by a similar magnitude, 95% CI [−12, 12]; p = .946; 
Hedge’s g = 0.07, 95% CI [−0.54, 0.68] (Figure 3b). Analysis of 
covariance revealed no influence of habitual caffeine intake on 
exercise performance, F(1, 43) = 0.013; p = .910; η2 = .00. Men p 
(COF: 451 ± 31 s; PLA 465 ± 38 s) completed the time trial 
moderately quicker than women, COF: 516 ± 42 s; PLA 526 ± 
40 s; F(1, 41) = 0.984; p = .761; 95% CI [−85, −38]; η2 = .40. p 
Figure 2 — (a) Distribution and individual salivary caffeine responses during the 5-km cycling time trial. (b) Individual changes in salivary caffeine 
concentration following coffee ingestion in habitually low- and high-caffeine users. 
(Ahead of Print) 
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Figure 3 — (a) Distribution and individual 5-km cycling time-trial time for completion in habitually low- and high-caffeine users. (b) Individual 
changes in time-trial duration (placebo time minus coffee time, where positive values represent a faster time following the ingestion of coffee) in habitually 
low- and high-caffeine users. 
However, no significant sex and trial interaction was observed, F(1, 
41) = 0.504; p = .482; η2 = .01, with men and women both improv-p 
ing by approximately 8 and 9 s, respectively, following coffee 
ingestion, and with only a Trivial trial × Sex × Habitual caffeine 
intake interaction, F(1, 41) = 0.984; p = .327; η2 = .02. Further-p 
more, in order to account for baseline performance (PLA) 
between low and high users, an analysis of covariance was 
performed using the PLA condition as a covariant, which dem-
onstrated no significant difference in the performance following 
the ingestion of coffee, F(1, 43) = 0.708; p = .405; η2p = .02, 
and as such, both groups improved by a similar magnitude 
(low users: 1.7 ± 2.8%; high users: 1.8 ± 2.0%). In addition, 
no order effect was observed, t(45) = 0.253; p = .802; Hedge’s 
g = 0.04, 95% CI [−0.37, 0.44]. Finally, no association was 
observed between habitual caffeine intake (r2 = .002; p = .828; 
Figure 4a) or postdrink salivary caffeine concentration (r2 = .002; 
p =.188; Figure 4b) and time-trial performance following coffee 
ingestion. 
A small condition and time interaction for blood lactate was 
observed, F(2, 88) = 6.818; p = .002; η2 = .13 (Table 1), with va-p 
lues higher at the completion of COF compared with PLA, 
p = .001; 95% CI [0.5, 1.8]; Hedge’s g = 0.42, 95% CI [0.01, 
0.84]. However, there were no differences observed between 
low- and high-caffeine users, F(1, 44) = 0.163; p = .688; η2 = .00. p 
Similarly, a small increase heart rate was observed during COF 
compared with PLA, F(1, 41) = 6.296; p = .016; 95% CI [1, 5]; 
η2p = .13 (Table 1), although only trivial differences, F(1,41) = 
0.829; p = .368; 95% CI [−9, 3]; η2 = .02 (Table 1), in heart rate p 
were observed between low- and high-caffeine users. 
Discussion 
The aim of the present study was to investigate the effect of habitual 
caffeine intake on 5-km cycling time-trial performance following 
the ingestion of coffee. Ingesting coffee, providing 3 mg/kg of 
caffeine improved 5-km cycling time-trial performance with simi-
lar performance observed between habitually low- and high-caf-
feine users. Consequently, habitual caffeine consumption did not 
affect the ergogenic effect of coffee ingestion prior to a 5-km 
cycling time trial. 
Ingesting coffee reduced 5-km cycling time-trial completion 
time by 1.7 ± 2.6% (8 ± 12 s), with low users improving by 
1.7 ± 2.8% (9 ± 14 s) and high users by 1.8 ± 2.0% (8 ± 10 s). 
These findings support Clarke et al. (2019), who observed that 
coffee providing 3 mg/kg of caffeine improved 5-km cycling time-
trial performance by 1.9% (men: 2.1% and women: 1.8%) com-
pared with a PLA and Clarke et al. (2018) where the ingestion of 
caffeinated coffee providing 3 mg/kg of caffeine improved 1-mile 
race time by 1.9% compared with a PLA. In addition, Wiles et al. 
(1992) reported that the ingestion of 3 g of caffeinated coffee, 
containing approximately 150–200 mg of caffeine, improved 
1500-m treadmill running performance by 4.2 s (1.4%) when 
compared with decaffeinated coffee. Similarly, Hodgson et al. 
(2013) demonstrated that coffee and caffeine (5 mg/kg) ingestion 
improved time-trial performance by approximately 5%. Despite 
these overall observations, individual performance responses to 
coffee ingestion do exist as highlighted in Figure 3b; that is, the 
magnitude of performance change varies between individuals 
(−7.3% to 8.1%). Consequently, habitual caffeine intake is a 
potential factor for the underlying heterogeneous responses (Bell 
& McLellan, 2002). However, empirically this suggestion is not 
conclusive; three studies have reported a blunting of caffeine’s 
acute ergogenic effects with habitual use (Beaumont et al., 2017; 
Bell & McLellan, 2002; Lara et al., 2019), and two reported no 
differences in response to acute caffeine ingestion between indi-
viduals with different habitual caffeine intakes (Dodd et al., 1991; 
Gonçalves et al., 2017). The present study suggests there is no 
association between habitual caffeine intake and the absolute 
change in the 5-km time-trial performance (Figure 4a), refuting 
the suggestion that habitual caffeine intake might reduce the 
ergogenic effect of coffee ingestion. One possible explanation 
for this occurrence is the limited association between preexercise 
salivary caffeine concentration and exercise performance 
(Figure 4b). Therefore, the findings of the present study add to 
the body of evidence suggesting that habitual caffeine consumption 
does not negatively affect the ergogenic effect of caffeine or coffee. 
(Ahead of Print) 
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Figure 4 — (a) Relationship between individual changes in time-trial duration (placebo – coffee, where positive values represents a faster time 
following the ingestion of coffee) and habitual daily caffeine intake. (b) Relationship between postdrink salivary caffeine concentration and time-trial 
duration. 
However, it should be noted that the concept that habitual caffeine 
intake moderates the acute ergogenic effects of caffeine supple-
mentation was derived from animal studies with very high doses 
(i.e., 20 mg/kg) (Fredholm, 1982), and as such may not be relevant 
to humans. 
The metabolism of caffeine in the liver is largely dependent on 
the CYP1A2 isoform of cytochrome 450 and Djordjevic et al. 
(2010) reported that the daily consumption of at least 3 cups of 
coffee, defined as “heavy drinkers,” increased CYP1A2 activity 
potentially increasing caffeine metabolism. Furthermore, Sven-
ningsson et al. (1999) reported alterations in gene expression 
within the striatum albeit in rats, which may be crucial in the 
development of tolerance to caffeine, potentially affecting caffeine 
metabolism, and thus altering the ergogenic effect of caffeine and 
coffee. When specifically examining exercise of the nature in the 
present study, the primary mechanisms by which caffeine exerts 
its ergogenic effects are considered to arise from the antagonism 
of adenosine receptors leading to an increase in neurotransmitter 
release and motor unit firing rates, pain suppression, reduced 
fatigue, and improved neuromuscular performance (Graham, 
2001). Furthermore, Meeusen et al. (2013) suggested that both 
motor effects and motivational aspects increase when caffeine 
blocks adenosine receptors, creating a greater dopaminergic drive, 
and thus enhancing 5-km performance. However, data suggest that 
habitual intake of caffeine is associated with an increased number 
of adenosine receptors (Fredholm, 1982) attenuating caffeine’s 
(Ahead of Print) 
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Table 1 Mean ± SD Heart Rate and Blood Lactate Concentrations During the 5-Km Cycling Time Trial in Habitually 
Low- and High-Caffeine Users 
Placebo Coffee 
Variable Predrink Postdrink Completion Predrink Postdrink Completion 
Heart rate (beats per minute) 
Overall 69 ± 12 68 ± 13 171 ± 12 71 ± 14 70 ± 13 180 ± 11 
Low user 71 ± 14 68 ± 14 173 ± 12 71 ± 15 71 ± 15 179 ± 11 
High user 71 ± 10 73 ± 10 178 ± 12 74 ± 10 74 ± 10 182 ± 11 
Blood lactate (mmol/L) 
Overall 1.9 ± 0.8 2.3 ± 1 12.0 ± 2.8 2.1 ± 0.9 2.6 ± 1.2 13.2 ± 2.8 
Low user 2.0 ± 0.9 2.3 ± 1.1 12.3 ± 2.8 2.2 ± 1.0 2.5 ± 1.1 13.1 ± 2.6 
High user 1.7 ± 0.4 2.3 ± 0.8 11.4 ± 3.0 2.0 ± 0.9 2.9 ± 1.4 13.4 ± 3.3 
stimulatory effects (Svenningsson et al., 1999). In addition, a 
caffeine-induced increase in the secretion of β-endorphins 
(Laurent et al., 2000) may be a potential mechanism via which, 
caffeine attenuates pain sensation and rating of perceived exertion 
during exercise, thereby decreasing perceptions of effort and/or 
improving performance, as observed in the present study. How-
ever, Haskell et al. (2005) reported that the ingestion of caffeine 
tended to improve mood and cognitive performance more in low-
caffeine users compared high. Consequently, while habitual caf-
feine consumption may cause alterations in caffeine metabolism, 
the efficacy of adenosine antagonism and mood, the evidence from 
the present study suggests that they do not translate into impaired 
exercise performance in high-caffeine users. 
On a practical level, Lara et al. (2019) reported that there is a 
progressive tolerance to caffeine ingestion, and there are sugges-
tions that the preexercise caffeine dose needs to exceed the level of 
habitual intake (Pickering & Kiely, 2018). However, the present 
study showed that the level of habitual caffeine ingestion was not 
associated with the magnitude of improvement in 5-km perfor-
mance following the ingestion of coffee providing 3 mg/kg of 
caffeine, a value below the habitual intake of the high users 
(6 ± 2 mg · kg−1 · day−1). Furthermore, Pickering and Kiely (2019) 
concluded that short-term precompetition caffeine withdrawal 
appears to offer little benefit, and given the potential negative 
side effects, withdrawal strategies are not recommended. In addi-
tion, Irwin et al. (2011) concluded that acute caffeine supplementation 
positively effects exercise performance and provides an ergogenic 
benefit in regular caffeine users regardless of any withdrawal period. 
Therefore, consuming coffee providing 3 mg/kg 60 min prior to 
exercise is a practical source of caffeine prior to exercise in habitual 
low- and high-caffeine users. However, given the individual response 
to caffeine, athletes should experiment with various doses and timing 
strategies when using caffeine to enhance performance (Pickering & 
Kiely, 2019). 
The present study is not without limitations. There are diffi-
culties with relying on self-report caffeine consumption question-
naires in order to determine habitual use of caffeine as participants 
may not be fully aware of what products contain caffeine, and the 
caffeine content in drinks can vary between caffeine sources and 
time points (Desbrow et al., 2007). Furthermore, the use of a 24-hr 
dietary record to ensure pretrial standardization, while being an 
acceptable method, under reporting can occur (Poslusna, Ruprich, 
de Vries, Jakubikova, & van’t Veer, 2009). In addition, the baseline 
salivary caffeine concentrations suggest that possibly not all 
participants abstained from caffeine for 12 hr prior to each trial. 
However, both factors are likely to provide a more ecologically 
valid condition and represent typical precompetition preparation. 
Furthermore, there are also important strengths to this study, 
namely the caffeine content of the coffee and salivary caffeine 
concentration has been assessed. 
Conclusions 
Habitual caffeine consumption did not affect the ergogenic effect of 
coffee ingestion during 5-km cycling time trial. Furthermore, 
ingesting coffee providing 3 mg/kg of caffeine increased salivary 
caffeine levels and improved 5-km cycling time-trial performance, 
and thus, coffee is a practical source of caffeine. However, the 
underlying mechanisms are not fully elucidated, and given the 
limitations listed, further investigations are required to understand 
the impact of habitual caffeine ingestion on the ergogenic effect of 
coffee and caffeine ingestion. 
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